by Stacey Johnson | Aug 22, 2023
It’s exciting news that there are close to 2,000 advanced therapies currently in clinical trials around the world. But is it good news? It’s exciting to see how far the cell and gene therapy (CGT) industry has come and how quickly the pipeline is growing. It’s...
by Michael May | Aug 22, 2023
The 10-year boom of the cell and gene therapy (CGT) industry has inevitably come to an end: public CGT valuations are way down, companies are settling into cash conservation mode, unrealistic salary demands are being replaced by layoffs, and the vultures circling with...
by Don Gibbons | Aug 22, 2023
If you are reading all or parts of this blog carnival you are probably a fan of stem cells and regenerative medicine more broadly. You probably believe this field can and will change the way medicine is practiced. But how careful are you when choosing your words to...
by Cal Strode | Aug 16, 2023
In a wide-ranging interview with POLITICO reporter Robert King at the Next Generation of Health Care Therapies event, Dr. Peter Marks, Director, Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA), discussed cell and gene...
Comments